Author:
Hamberg Paul,Donders Richard C. J. M.,ten Bokkel Huinink Daan
Publisher
Oxford University Press (OUP)
Reference7 articles.
1. Cunningham D, Glimelius B. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy.
Semin Oncol1999
;
26
(suppl 5):
6
–12.
2. Sevilla Garcia I, Rueda A, Alba E. Irinotecan-induced central nervous system toxicity: a case report.
J Natl Cancer Inst1999
;
91
:
647
.
3. Baz DV, Bofill JS, Nogueira JA. Irinotecan-induced dysarthria.
J Natl Cancer Inst2001
;
93
:
1419
–20.
4. Ceccaldi B, Kara F, Mommeja-Marin H, Begue M, Saint Blancard P, Le Marec E, et al. Dysarthrie lors de l'administration d'irinotecan.
Rev Med Interne2002
;
23
:
950
–1.
5. Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
Clin Cancer Res2001
;
7
:
2182
–94.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献